Anita Sook Yee Chan

Dr. Anita Sook Yee Chan

Assistant Professor, Singapore National Eye Centre, Singapore City, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CYClarice H. Y. Yeoh
Clarice H. Y. Yeoh
JLJerome Lee
Jerome Lee
BLBlanche XH Lim
Blanche XH Lim
GSGangadhara Sundar
Gangadhara Sundar
Jodhbir S. MehtaJodhbir S. Mehta
Jodhbir S. Mehta
CLChris Lim
Chris Lim
The rise of primary topical monotherapy with chemotherapeutic drugs and immunomodulatory agents represents an increasing recognition of the medical management of ocular surface squamous neoplasia (OSSN), which may replace surgery as the standard of care in the future. Currently, there is no consensus regarding the best way to manage OSSN with no existing guidelines to date. This paper seeks to evaluate evidence surrounding available treatment modalities and proposes an approach to management. The approach will guide ophthalmologists in selecting the most appropriate treatment regime based on patient and disease factors to minimize treatment related morbidity and improve OSSN control. Further work can be done to validate this algorithm and to develop formal guidelines to direct the management of OSSN.

11 December 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
EYEkaterina Yonova-Doing
Ekaterina Yonova-Doing
WZWanting Zhao
Wanting Zhao
RIRobert P. Igo
Robert P. Igo
CWChaolong Wang
Chaolong Wang
PSPeriasamy Sundaresan
Periasamy Sundaresan
CCChing-Yu Cheng
Ching-Yu Cheng
Nuclear cataract is the most common type of age-related cataract and a leading cause of blindness worldwide. Age-related nuclear cataract is heritable (h2 = 0.48), but little is known about specific genetic factors underlying this condition. Here we report findings from the largest to date multi-ethnic meta-analysis of genome-wide association studies (discovery cohort N = 14,151 and replication N = 5299) of the International Cataract Genetics Consortium. We confirmed the known genetic association of CRYAA (rs7278468, P = 2.8 × 10−16) with nuclear cataract and identified five new loci associated with this disease: SOX2-OT (rs9842371, P = 1.7 × 10−19), TMPRSS5 (rs4936279, P = 2.5 × 10−10), LINC01412 (rs16823886, P = 1.3 × 10−9), GLTSCR1 (rs1005911, P = 9.8 × 10−9), and COMMD1 (rs62149908, P = 1.2 × 10−8). The results suggest a strong link of age-related nuclear cataract with congenital cataract and eye development genes, and the importance of common genetic variants in maintaining crystalline lens integrity in the aging eye.

1 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LTLaura Ling Ying Tan
Laura Ling Ying Tan
JHJiancheng Hong
Jiancheng Hong
WGWei Lin Goh
Wei Lin Goh
ECEsther Wei Yin Chang
Esther Wei Yin Chang
VYValerie Shiwen Yang
Valerie Shiwen Yang
JCJason Yongsheng Chan
Jason Yongsheng Chan
Ocular melanomas are uncommon cancers in Southeast Asia unlike in the West. We conducted a retrospective review of patients (n = 44) with histologically-proven ocular melanoma within a multi-ethnic Asian cohort from Singapore. Clinicopathological features and relapse patterns were examined, and survival outcomes of interest included recurrence-free survival (RFS) and overall survival (OS). Survival analysis was performed using the Kaplan–Meier method and multivariable Cox proportional regression. The study cohort included 18 male and 26 female patients, with a median age of 52 years (range 8–78). Median follow-up was 154 months. For uveal melanomas (n = 29), the 5-year RFS and OS was 56.8% and 76.6%, respectively; whilst for conjunctival melanomas (n = 15), the 5-year RFS and OS was 30.1% and 68.8%, respectively. Fifteen patients (38.5%) eventually developed metastasis, following which the median survival was only 17 months. Multivariate analysis demonstrated that higher T stage was a significant independent predictor for both OS (HR 8.69, 95% CI 1.03 to 73.09, p = 0.047) and RFS (HR 11.62, 95% CI 2.45 to 55.00, p = 0.002). Smoking history was independently predictive of better RFS (HR 0.08, 95% CI 0.01 to 0.78, p = 0.030). In conclusion, our study demonstrates the poor ocular melanoma outcomes in Southeast Asians, highlighting the necessity for urgent research in this area of unmet clinical need.

22 August 2019 in Blood
Verified
Journal Article
Closed access
PDF file
WTWei Jian Tan
Wei Jian Tan
MWMona Meng Wang
Mona Meng Wang
PRPaola Ricciardi-Castagnoli
Paola Ricciardi-Castagnoli
TTTiffany Tang
Tiffany Tang
SCSoon Phaik Chee
Soon Phaik Chee
Anita Sook Yee ChanAnita Sook Yee Chan
Anita Sook Yee Chan

1 July 2021 in Ophthalmology
Verified
Journal Article
Open access
WTWei Jian Tan
Wei Jian Tan
MWMona Meng Wang
Mona Meng Wang
PCPaola Ricciardi Castagnoli
Paola Ricciardi Castagnoli
TTTiffany Tang
Tiffany Tang
Anita Sook Yee ChanAnita Sook Yee Chan
Anita Sook Yee Chan
TLTong Seng Lim
Tong Seng Lim
To test whether analyzing DEPArray (Menarini Silicon Biosystems) isolated single B cells from the vitreous fluid can reveal crucial genomic and clinicopathological features to distinguish patients with vitreoretinal lymphoma (VRL) from those with chronic inflammation using immunoglobulin heavy chain (IGH), disease biomarker myeloid differentiation primary response 88 (MYD88)L265P mutation, and copy number profiling. A single-center, retrospective study. Remnant vitreous biopsies from 7 patients with VRL and 4 patients with chronic inflammation were acquired for molecular analysis. Vitreous fluid samples were prefixed in PreservCyt (Hologic) and underwent cytologic analysis and immunohistochemistry examination. Single cells were isolated using the DEPArray NxT system, followed by downstream genomic analysis. The frequencies of the dominant IGH and MYD88L265P mutation and the genome-wide copy number aberration (CNA) profiles of individual vitreous-isolated B cells were characterized. An average of 10 to 13 vitreous B cells were used in the single-cell IGH and MYD88 analyses. Higher frequencies of dominant IGH (88.8% ± 13.2%) and MYD88L265P mutations (35.0% ± 31.3%) were detected in patients with VRL than in patients with chronic inflammation (65.9% ± 13.4% and 1.5% ± 2.6% for IGH and MYD88L265P, respectively). In a cytology-proven VRL case, all 15 vitreous isolated B cells were derived from the same clone with 100% paired IGH: immunoglobulin light chain (IGK) sequences. Genome-wide copy number profiling revealed a high degree of similarity between B cells from the same patient with VRL, with extensive gains and losses at the same areas across the whole genome. In addition, 14 of 15 B cells showed a BCL2/JH t(14;18) translocation, confirming cellular malignancy with a clonal origin. Clustering analysis of the copy number profiles revealed that malignant B cells derived from different patients with VRL had no common genome-wide signatures. Single B-cell genomic characterization of the IGH, MYD88L265P mutation, and copy number profile enables VRL diagnosis. Because our study involved only a small cohort, these meaningful proof-of-concept data now warrant further investigation in a larger patient cohort.

11 January 2021 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
WTWei Jian Tan
Wei Jian Tan
MWMona Meng Wang
Mona Meng Wang
PRPaola Ricciardi-Castagnoli
Paola Ricciardi-Castagnoli
Anita Sook Yee ChanAnita Sook Yee Chan
Anita Sook Yee Chan
TLTong Seng Lim
Tong Seng Lim
Vitreoretinal lymphoma (VRL) is a rare ocular malignancy that manifests as diffuse large B-cell lymphoma. Early and accurate diagnosis is essential to prevent mistreatment and to reduce the high morbidity and mortality associated with VRL. The disease can be diagnosed using various methods, including cytology, immunohistochemistry, cytokine analysis, flow cytometry, and molecular analysis of bulk vitreous aspirates. Despite these options, VRL diagnosis remains challenging, as samples are often confounded by low cellularity, the presence of debris and non-target immunoreactive cells, and poor cytological preservation. As such, VRL diagnostic accuracy is limited by both false-positive and false-negative outcomes. Missed or inappropriate diagnosis may cause delays in treatment, which can have life-threatening consequences for patients with VRL. In this review, we summarize current knowledge and the diagnostic modalities used for VRL diagnosis. We also highlight several emerging molecular techniques, including high-resolution single cell-based analyses, which may enable more comprehensive and precise VRL diagnoses.